Most Read Articles
30 Nov 2018
New drug applications approved by US FDA as of 16 - 30 November 2018 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.
Roshini Claire Anthony, 6 days ago

A combination of tocilizumab and methotrexate reduced disease activity at 2 years compared with methotrexate plus prednisone in patients with early rheumatoid arthritis (RA), an effect not demonstrated with tocilizumab monotherapy.

Roshini Claire Anthony, 4 days ago

The use of intramuscular depot medroxyprogesterone acetate (DMPA-IM) did not increase a woman’s risk of acquiring HIV compared with the use of a copper intrauterine device (IUD) or a levonorgestrel implant, results of a study conducted by the ECHO* Trial Consortium show.

14 May 2019
At the recent GLYCEMIC GUARDIANS™ dinner symposium, three eminent speakers spoke on theindispensable role of medical nutrition therapy (MNT) in improving outcomes for patients with type2 diabetes (T2D).

Multimodal approach reduces missed opportunities for influenza vaccination in RA patients

30 Sep 2018

Multimodal approach reduces missed opportunities for influenza vaccination in RA patients

Using a multimodal intervention may improve uptake of influenza vaccination in patients with rheumatoid arthritis (RA), reports a study, adding that some subgroups may need a more potent approach for equivalent efficacy.

Of the 228 patients with RA who participated in the study (904 preintervention visits), 197 returned for at least one postintervention visit (721 postintervention visits). There was a 47-percent preintervention frequency of any missed opportunities for influenza vaccination, and this decreased to 23 percent postintervention (p<0.001).

The relative hazard among those vaccinated for influenza vaccination post vs preintervention period was 1.24 (p=0.038).

Each of the following was independently associated with missed opportunities preintervention: younger age, less frequent office visits, higher erythrocyte sedimentation rate and negative attitudes about vaccines. These factors no longer correlated with missed opportunities postintervention.

However, the intervention appeared to be not as effective in the following: non-Hispanic black patients, non-English speakers, those residing outside of the New York City metropolitan area and those reporting prior adverse reactions to vaccines.

This study recruited RA patients from a single centre. The authors tracked each rheumatology outpatient visit for missed opportunities for influenza vaccination, defined as a visit in which an unvaccinated patient without contraindications remained unvaccinated or lacked documentation of vaccine recommendation in the electronic medical record (EMR).

Subsequently, providers received a multimodal intervention consisting of an education session, EMR alerts and weekly provider-specific e-mail reminders. The authors compared missed opportunities pre- and postintervention, and analysed the determinants of missed opportunities.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Pharmacist - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
30 Nov 2018
New drug applications approved by US FDA as of 16 - 30 November 2018 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.
Roshini Claire Anthony, 6 days ago

A combination of tocilizumab and methotrexate reduced disease activity at 2 years compared with methotrexate plus prednisone in patients with early rheumatoid arthritis (RA), an effect not demonstrated with tocilizumab monotherapy.

Roshini Claire Anthony, 4 days ago

The use of intramuscular depot medroxyprogesterone acetate (DMPA-IM) did not increase a woman’s risk of acquiring HIV compared with the use of a copper intrauterine device (IUD) or a levonorgestrel implant, results of a study conducted by the ECHO* Trial Consortium show.

14 May 2019
At the recent GLYCEMIC GUARDIANS™ dinner symposium, three eminent speakers spoke on theindispensable role of medical nutrition therapy (MNT) in improving outcomes for patients with type2 diabetes (T2D).